Ignite Creation Date:
2024-05-06 @ 7:21 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05983237
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-14
First Post:
2023-07-11
Brief Title:
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Sponsor:
Jun Guo
Organization:
Peking University Cancer Hospital Institute
Organization Data
Organization:
Peking University Cancer Hospital Institute
Class:
OTHER
Study ID:
MA-MM-Ⅱ-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jun Guo
Lead Sponsor Class:
OTHER
Responsible Party:
Jun Guo
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Peking University Cancer Hospital Institute
Old Name:
None
Old Organization:
None